NEW YORK ( TheStreet) -- BioMimetic Therapeutics (Nasdaq: BMTI) hit a new 52-week low Wednesday as it is currently trading at $6.17, below its previous 52-week high of $14.80 with 124,261 shares traded as of 11:45 a.m. ET. Average volume has been 537,400 shares over the past 30 days. BioMimetic has a market cap of $185.8 million and is part of the health care sector and health services industry. Shares are down 50.2% year to date as of the close of trading on Tuesday. BioMimetic Therapeutics, Inc., a biotechnology company, engages in the development and commercialization of regenerative protein therapeutic-device combination products for the treatment of musculoskeletal injuries and conditions affecting bones, tendons, ligaments, and cartilage.
- Practice your BMTI trading strategies and win cash in our stock game.